EFRI-BioFlex: A Flexible Glucose Fuel Cell

EFRI-BioFlex:灵活的葡萄糖燃料电池

基本信息

  • 批准号:
    1606406
  • 负责人:
  • 金额:
    $ 95.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-11-01 至 2018-08-31
  • 项目状态:
    已结题

项目摘要

This proposal attempts to create a flexible glucose fuel cell and associated ultra-low-power bioelectronics for self-powered brain implants of the future. The flexible glucose fuel cell enables a 20x increase in volumetric density with 320 uW of power available from a biocompatible 1cm (d) x 4 cm (l) device, which is implanted in the subarachnoid spaces of the brain and spinal cord. Thus, fully implantable brain implants for paralysis with novel state-of-the-art ultra-low-power electronics for neural recording, stimulation, decoding, and wireless communication, which consume 95 uW in total, can be powered with a safety factor of 3x that allows for fuel-cell output variation over time. This proposal attempts to test a fully functional brain-implant system in a smaller geometry 3 mm (d) x 3mm (l) device in a rat to ensure chronic ( 6 months) long-term biocompatibility and performance that meets our power budget. The use of the cerebrospinal fluid as a power source, which has a 200x lower protein count, and almost million-fold lower cell count, and only a 2x lower glucose content, provides a novel site for implantation significantly different from prior work in blood plasma or interstitial fluid. This novel intended site of implantation along with our use of materials and techniques that have been proven to increase biocompatibility, such as Nafion encapsulation, enhance longevity. The flexible glucose fuel cell will be fabricated using well-known semiconductor fabrication techniques on a silicon wafer enabling manufacturing scalability and ease of integration with electronics on the same wafer. Intellectual Merit: This work combines innovations and knowledge from several disciplines to potentially create a paradigm-changing capability in the field of medical implants: 1) Prior enzyme-based glucose fuel cells have been plagued by enzyme-degradation issues that have led them to be inefficient after a few short-term months. Abiotic fuel cells are more suited for long-term chronic operation but have relatively low power outputs. The creation of an abiotic flexible glucose fuel cell increases the volumetric density of available power by more than an order of magnitude while preserving the benefits of long-term abiotic operation. 2) The use of ultra-low-power bioelectronics that achieves state-of-the-art performance in all aspects of a brain-implant system enables miniature glucose fuel cells to meet the power budget needed for intended medical applications with even a safety factor of 3x and to fit within tightly constrained body spaces. 3) The use of standard semiconductor fabrication techniques enables entire flexible medical implants with their own power source and electronics to be cheaply fabricated in a rolled-up geometry without sacrificing performance as in systems made with flexible organic electronics. 4) The glucose-rich cerebrospinal fluid is highly abiotic (free of cells) and highly protein free making it an ideal source for providing fuel while not causing electrode bio-fouling. This work could enable glucose fuel cells to become practical after four decades of research.Broader Impact:Glucose fuel cells have use in the treatments of cardiac arrhythmia, diabetes, epilepsy, deep brain disorders, and cancer tumor monitoring. Rolled-up ?sugar powered batteries? may be used in non-invasive wireless medical monitoring or in wearable and flexible electronic systems. The flexible glucose fuel cell can help solve a national challenge for non-toxic (unlike batteries), renewable, carbon-neutral, energy sources that are practical. The PI plans to introduce an in-vitro glucose-fuel-cell powered ECG as a project in his course in bioelectronics at MIT that has been taught for over 10 years at MIT The Research Team further plans to develop a module that will use microfluidic setup to monitor output protein concentrations in cells at the fuel-cell output voltages and introduce the platform to the do-it-yourself community at MIT through programs such as Lifelong Kindergarten and ?Science Saturday? at Lincoln Lab. The PI plans to recruit under-represented students from his active participation in the admissions programs of the Computational and Systems Biology, Biophysics, Synthetic Biology, and Bioelectrical endeavors at MIT. The investigators will participate in SEED (Saturday Engineering Enrichment and Discovery) Academy, which enrolls students from Boston, Cambridge, and Lawrence Public Schools; they will also work closely with the Society of Women Engineers (SWE) to attract promising young women into biomedical and bioengineering research; and, they will work actively with the MIT Summer Research Program (MSRP), which has traditionally included underrepresented students into research programs. Thus the proposal will have broad technical impact, broad educational impact, and broaden societal participation.
这项提议试图创造一种灵活的葡萄糖燃料电池和相关的超低功耗生物电子设备,用于未来的自供电大脑植入物。这种灵活的葡萄糖燃料电池可以使体积密度增加20倍,其功率为320 uW,来自一个生物相容性的1cm (d) x 4cm (l)的装置,该装置被植入大脑和脊髓的蛛网膜下腔。因此,用于瘫痪的完全植入式大脑植入物配备了最先进的超低功耗电子设备,用于神经记录、刺激、解码和无线通信,总功耗为95 uW,其供电安全系数为3倍,允许燃料电池输出随时间变化。该提案试图在大鼠体内测试一个更小的几何尺寸为3mm (d) x 3mm (l)的大脑植入系统,以确保慢性(6个月)长期生物相容性和性能满足我们的功率预算。使用脑脊液作为动力源,其蛋白质计数降低了200倍,细胞计数降低了近百万倍,葡萄糖含量仅降低了2倍,这为植入提供了一个新的位置,与之前在血浆或间质液中的工作有显著不同。这种新颖的植入部位以及我们使用的材料和技术已经被证明可以提高生物相容性,如Nafion胶囊,可以延长寿命。柔性葡萄糖燃料电池将采用著名的半导体制造技术在硅片上制造,使制造可扩展性和易于与同一硅片上的电子设备集成。智力优势:这项工作结合了来自多个学科的创新和知识,有可能在医疗植入领域创造一种改变范式的能力:1)先前的酶基葡萄糖燃料电池一直受到酶降解问题的困扰,导致它们在几个月后效率低下。非生物燃料电池更适合长期慢性操作,但功率输出相对较低。一种非生物柔性葡萄糖燃料电池的创建增加了可用功率的体积密度超过一个数量级,同时保留了长期非生物操作的好处。2)超低功耗生物电子学的使用在脑植入系统的各个方面都达到了最先进的性能,使微型葡萄糖燃料电池能够满足预期医疗应用所需的功率预算,甚至安全系数为3倍,并且能够适应严格限制的身体空间。3)使用标准的半导体制造技术,使得整个柔性医疗植入物具有自己的电源和电子器件,可以在卷起来的几何形状中廉价地制造,而不会牺牲柔性有机电子系统的性能。4)富含葡萄糖的脑脊液是高度非生物的(无细胞)和高度无蛋白质的,使其成为提供燃料的理想来源,同时不会引起电极生物污染。经过40年的研究,这项工作可能使葡萄糖燃料电池成为现实。更广泛的影响:葡萄糖燃料电池用于治疗心律失常、糖尿病、癫痫、深部脑疾病和癌症肿瘤监测。卷起来的?糖动力电池?可用于非侵入式无线医疗监测或可穿戴和柔性电子系统。灵活的葡萄糖燃料电池可以帮助解决国家面临的一项挑战,即无毒(与电池不同)、可再生、碳中性、实用的能源。PI计划在麻省理工学院的生物电子学课程中引入一个体外葡萄糖燃料电池供电的ECG项目,该项目已经在麻省理工学院教授了10多年。研究小组进一步计划开发一个模块,该模块将使用微流体装置来监测燃料电池输出电压下细胞中的输出蛋白质浓度,并通过终身幼儿园和?科学周六?在林肯实验室。PI计划从他积极参与麻省理工学院计算与系统生物学、生物物理学、合成生物学和生物电学的招生项目中招收代表性不足的学生。研究人员将参加SEED(周六工程充实和发现)学院,该学院招收来自波士顿、剑桥和劳伦斯公立学校的学生;她们还将与女工程师协会(SWE)密切合作,吸引有前途的年轻女性参与生物医学和生物工程研究;并且,他们将积极参与麻省理工学院暑期研究项目(MSRP),该项目传统上包括代表性不足的学生参加研究项目。因此,该提案将产生广泛的技术影响,广泛的教育影响,并扩大社会参与。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rahul Sarpeshkar其他文献

Lorenzian-Chaos-Like Dynamics in Viral-Immune Cytomorphic Chips
病毒免疫细胞形态芯片中的洛伦兹混沌动力学
Gene syntaxes modulate gene expression and circuit behavior on plasmids
  • DOI:
    10.1186/s13036-025-00493-0
  • 发表时间:
    2025-03-27
  • 期刊:
  • 影响因子:
    6.500
  • 作者:
    Yijie Deng;Hannah E. Maurais;Kai Etheridge;Rahul Sarpeshkar
  • 通讯作者:
    Rahul Sarpeshkar

Rahul Sarpeshkar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rahul Sarpeshkar', 18)}}的其他基金

FET: Small: Rapid and Rational Drug-Cocktail Formulation and Discovery Via Electronic Circuits
FET:小型:通过电子电路快速合理地配制和发现药物混合物
  • 批准号:
    2240264
  • 财政年份:
    2023
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EAGER: Hybrid Analog-Digital Automata in Microbial Cells
EAGER:微生物细胞中的混合模拟数字自动机
  • 批准号:
    1348519
  • 财政年份:
    2013
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFlex: A Flexible Glucose Fuel Cell
EFRI-BioFlex:灵活的葡萄糖燃料电池
  • 批准号:
    1332250
  • 财政年份:
    2013
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
Career:The Adaptive Silicon Cochlea: Biology, VLSI, and Applications
职业:自适应硅耳蜗:生物学、VLSI 和应用
  • 批准号:
    9984451
  • 财政年份:
    2000
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant

相似海外基金

EFRI BioFlex: Electrically Mediated Complex Tissue Regeneration
EFRI BioFlex:电介导的复杂组织再生
  • 批准号:
    1332329
  • 财政年份:
    2013
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFlex: Cellphone-based Digital Immunoassay Platform for High-throughput Sensitive and Multiplexed Detection and Distributed Spatio-Temporal Analysis of Influenza
EFRI-BioFlex:基于手机的数字免疫分析平台,用于流感的高通量灵敏多重检测和分布式时空分析
  • 批准号:
    1332275
  • 财政年份:
    2013
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFlex: Hybrid polymer-paper based multi-sensor implants for continuous remote monitoring
EFRI-BioFlex:基于混合聚合物纸的多传感器植入物,用于连续远程监控
  • 批准号:
    1332394
  • 财政年份:
    2013
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFlex: A Flexible Glucose Fuel Cell
EFRI-BioFlex:灵活的葡萄糖燃料电池
  • 批准号:
    1332250
  • 财政年份:
    2013
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFlex: Miniature, low-cost fiber-optics technology for measurement of tissue structure at sub-diffractional length scales: a platform for cancer screening
EFRI-BioFlex:用于在亚衍射长度尺度上测量组织结构的微型、低成本光纤技术:癌症筛查平台
  • 批准号:
    1240416
  • 财政年份:
    2012
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFlex: Rapid Identification of Blood, Urine, and Saliva Toxins and Bacterial Infections with a SERS/LSS Flexible System
EFRI-BioFlex:使用 SERS/LSS 灵活系统快速识别血液、尿液和唾液毒素以及细菌感染
  • 批准号:
    1240410
  • 财政年份:
    2012
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI-BioFLEX: Tissue Engineered Flexible Sensors, Actuators and Electronics for Chronic Wound Management
EFRI-BioFLEX:用于慢性伤口管理的组织工程柔性传感器、执行器和电子设备
  • 批准号:
    1240443
  • 财政年份:
    2012
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
EFRI BioFlex: Flexible Resorbable Organic and Nanomaterial Therapeutic Systems (FRONTS)
EFRI BioFlex:灵活的可吸收有机和纳米材料治疗系统 (FRONTS)
  • 批准号:
    1240380
  • 财政年份:
    2012
  • 资助金额:
    $ 95.73万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了